These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4005864)

  • 1. Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents.
    Wheeler GP; Adamson DJ; Webster J
    Cancer Res; 1985 Jul; 45(7):3400-2. PubMed ID: 4005864
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents.
    Schmid FA; Otter GM; Mehta BM
    Cancer Res; 1985 Jan; 45(1):40-4. PubMed ID: 3965147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug sensitivity of methylnitrosourea- and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea-resistant L1210 lines.
    Schmid FA; Otter GM; Chen CF
    Cancer Res; 1986 Sep; 46(9):4469-71. PubMed ID: 3731103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.
    Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
    Cancer Chemother Rep 2; 1972 Nov; 3(1):1-69. PubMed ID: 4660732
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II).
    Macquet JP; Cros S; Armand JP
    Cancer Res; 1984 Sep; 44(9):3736-43. PubMed ID: 6540142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative comparisons between carcinogenicity, mutagenicity and electrophilicity of direct-acting N-nitroso compounds and other alkylating agents.
    Bartsch H; Malaveille C; Tomatis L; Brun G; Dodet B; Terracini B
    IARC Sci Publ; 1982; (41):525-32. PubMed ID: 6754595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenic and alkylating activities of 3-methyl-1-phenyltriazenes and their possible role as carcinogenic metabolites of the parent dimethyl compounds.
    Malaveille C; Brun G; Kolar G; Bartsch H
    Cancer Res; 1982 Apr; 42(4):1446-53. PubMed ID: 7060018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas.
    Wheeler GP; Bowdon BJ; Grimsley JA; Lloyd HH
    Cancer Res; 1974 Jan; 34(1):194-200. PubMed ID: 4809457
    [No Abstract]   [Full Text] [Related]  

  • 9. Absence of cross-resistance to alkylating agents in cyclophosphamide-resistant L1210 leukemia.
    Wampler GL; Regelson W; Bardos TJ
    Eur J Cancer (1965); 1978 Sep; 14(9):977-82. PubMed ID: 710488
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential susceptibility and cytopathic alterations induced by PTT. 119, a new cancericidal compound, p-fluoro-Phe-L-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl.
    Yagi MJ; Bekesi JG
    Biomed Pharmacother; 1983; 37(7):329-38. PubMed ID: 6667339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1-nitrosourea and cyclophosphamide by vitamin A.
    Cohen MH; Carbone PP
    J Natl Cancer Inst; 1972 Apr; 48(4):921-6. PubMed ID: 5023689
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristics and response to certain cancer chemotherapeutic agents of an acute lymphocytic leukemia arising in a BALB-c times DBA-2F1 mouse.
    Yancey ST; Bleyer WA
    Cancer Res; 1974 Aug; 34(8):1866-9. PubMed ID: 4526157
    [No Abstract]   [Full Text] [Related]  

  • 13. Differences in the immunogenicity of leukemia L1210 sublines in DBA-2 mice.
    Mihich E; Kitano M
    Cancer Res; 1971 Dec; 31(12):1999-2003. PubMed ID: 5120297
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
    Brockman RW; Cheng YC; Schabel FM; Montgomery JA
    Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The detection of chemical mutagens using the L5178y-Asn-murine leukemia in vitro and in a host-mediated assay.
    Capizzi RL; Papirmeister B; Mullins JM; Cheng E
    Cancer Res; 1974 Nov; 34(11):3073-82. PubMed ID: 4370835
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of the asparagine auxotroph of the L5178Y murine leukemia for the detection of chemical mutagens in vitro and in the host-mediated assay.
    Capizzi RL; Summers WP; Papirmeister B
    Environ Health Perspect; 1973 Dec; 6():137-43. PubMed ID: 4360721
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cytogenetic characteristics of the leukemia L1210 strain in the development of drug resistance].
    Goncharova SA; Minenkova EA; Fomina MM; Demidova NS
    Eksp Onkol; 1984; 6(4):38-41. PubMed ID: 6499750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents.
    Chou TC; Schmid FA; Feinberg A; Philips FS; Han J
    Cancer Res; 1983 Jul; 43(7):3074-9. PubMed ID: 6189591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of preliminary irradiation of barley grain with low doses of x-rays on the mutagenic activity of several monofunctional alkylating agents.
    Olimpienko GS; Vorob'eva EA; Pechorina AN; Mitrofanov YA; Korotaeva SE
    Sov Genet; 1974 Nov; 9(1):19-24. PubMed ID: 4375859
    [No Abstract]   [Full Text] [Related]  

  • 20. Biology and karyology of murine leukemia L1210 xenografted to the hamster.
    Goldenberg DM
    Cancer Res; 1972 Apr; 32(4):813-24. PubMed ID: 5014792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.